Vishal Chandrakant Shah

Vishal Chandrakant Shah

Director Director DIN 00266264
DIN 00266264 First appointment Mar 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Vishal Chandrakant Shah

Data last updated:

Vishal Chandrakant Shah was a Director at Gene Biotech Private Limited (2009–2019) and Director at Planet Pharmaceutical Private Limited (from 2006). The companies operate in Pharma.

DIN 00266264
Primary Designation Director
Industry Pharma
First Appointment 22 Mar 2006
Oldest Company Age 20 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gene Biotech Private Limited U24233MH2001PTC133421
Director28 Dec 20092001₹5.99 Cr (FY 2025)Active
Director22 Mar 20062006Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Planet Pharmaceutical Private Limited
Gene Biotech Private Limited
Premium access

Shareholding and investment profile for Vishal Chandrakant Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishal Chandrakant Shah

Vishal Chandrakant Shah was first appointed on 22 Mar 2006 as Director at Planet Pharmaceutical Private Limited. The most recent appointment on record is 28 Dec 2009 at Gene Biotech Private Limited.

Vishal Chandrakant Shah held 2 earlier board appointments: Gene Biotech Private Limited (Director, 28 Dec 2009 to 31 Mar 2019); Planet Pharmaceutical Private Limited (Director, from 22 Mar 2006).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available